v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 25,415,921 $ 30,806,477
Prepaid expenses and other current assets 505,505 184,827
Total current assets 25,921,426 30,991,304
Goodwill 9,600,240 9,600,240
In-process research and development 4,800,000 4,800,000
Property and equipment, net 9,829 8,340
Right-of-use asset 101,974 184,229
Other non-current assets 0 18,996
Total assets 40,433,469 45,603,109
Current liabilities:    
Accounts payable 950,503 624,995
Accrued liabilities and other current liabilities 1,893,534 2,608,021
Deferred revenue 0 370,160
Operating lease liability 117,038 194,331
Total current liabilities 2,961,075 3,797,507
Deferred tax liability 201,792 201,792
Other non-current liabilities 0 17,129
Total liabilities 3,162,867 4,016,428
Commitments and contingencies (Note 4)
Stockholders’ equity:    
Common stock, $0.001 par value; 100,000,000 shares authorized at March 31, 2026 and December 31, 2025; 49,221,246 and 49,221,246 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively 49,221 49,221
Additional paid-in capital 480,998,367 480,413,839
Accumulated other comprehensive loss (127,390) (127,180)
Accumulated deficit (443,649,596) (438,749,199)
Total stockholders’ equity 37,270,602 41,586,681
Total liabilities and stockholders' equity $ 40,433,469 $ 45,603,109